Insulin lispro (Humalog)

DRUG5 trials

Sponsors

Pfizer, Becton, Dickinson and Company, Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 1Healthy

Phase 1

A Study of a New LY900014 Formulation in Healthy Participants

CompletedNCT02525744

Eli Lilly and CompanyHealthy

Start: 2015-08-31End: 2015-10-31Updated: 2020-05-19

A Study of Various Formulations of LY900014 in Healthy Participants

CompletedNCT02636361

Eli Lilly and CompanyHealthy

Start: 2015-12-31End: 2016-02-29Updated: 2020-05-13

A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump

CompletedNCT03056456

Eli Lilly and CompanyDiabetes Mellitus, Type 1

Start: 2017-02-23End: 2017-06-19Updated: 2020-05-01

Phase 2

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

CompletedNCT00553488

Becton, Dickinson and CompanyDiabetes Mellitus, Type 1

Start: 2007-09-30End: 2008-01-31Updated: 2008-08-22

Phase 4

A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

TerminatedNCT00356421

PfizerDiabetes Mellitus, Type 1

Start: 2006-11-30End: 2008-06-30Updated: 2009-09-02